PeptidePedia The community reference

Special:RecentChanges

Change log·6,798 revisions·page 55 of 68

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 6,798 changes are logged in total.

6,798Logged changes
575Bot edits
167Page creations
256Active editors

3 December 2024

  1. (diff | hist) m 19:47 Regulatory status by jurisdiction 2,139 ±0 MelanocortinMil (talk | contribs) expand §The categories [rollback]
  2. (diff | hist) m 18:12 Dipeptidyl peptidase-4 4,336 +168 GIP_Genoveva (talk | contribs) convert the receptor-distribution list to a table [rollback]
  3. (diff | hist) 15:35 Peptide harm reduction 2,056 +798 CostPerMgCory (talk | contribs) rm the telehealth provider name; the article describes the model, not the vendors [rollback]
  4. (diff | hist) m 10:49 Orforglipron 2,355 +781 RetatrutideRuben (talk | contribs) reorder the analogues chronologically rather than alphabetically [rollback]
  5. (diff | hist) N 09:00 Sangon Biotech 1,705 +1,705 SecondarySrc_Seb (talk | contribs) new article: supplier organisation, created after the notability discussion
  6. (diff | hist) m 08:25 Subcutaneous injection 3,730 +40 EscalationEira (talk | contribs) clarify that the figure is per dose, not per vial [rollback]
  7. (diff | hist) m 06:13 Triple agonist 2,546 ±0 ColdChainCleo (talk | contribs) rm duplicated pharmacokinetics — the same figures appear in the infobox [rollback]
  8. (diff | hist) m 01:20 Fmoc chemistry 3,388 ±0 TierTwoTansy (talk | contribs) fix a broken wikilink [rollback]
  9. (diff | hist) 00:29 Lot traceability 3,642 +848 VerifyVesna (talk | contribs) state what the certificate actually carries, field by field [rollback]

2 December 2024

  1. (diff | hist) 18:54 Vial filling and stoppering 2,748 +268 TirzTaxonomist (talk | contribs) state that overlay gas is used and name it [rollback]
  2. (diff | hist) m 17:59 LEADER trial 2,357 ±0 ShortageShona (talk | contribs) correct the endpoint hierarchy — that was a secondary endpoint [rollback]
  3. (diff | hist) m 15:43 Peptide 4,033 ±0 SVG_Solomon (talk | contribs) add the cross-link to the temperature-excursion article [rollback]
  4. (diff | hist) 15:09 Vial 13,182 +303 PrepHPLC_Pia (talk | contribs) expand §Vials in unregulated distribution [rollback]
  5. (diff | hist) m 10:10 Amylin receptor agonist 2,905 +334 ExenatideEzra (talk | contribs) split overlong sentence [rollback]
  6. (diff | hist) N 09:00 Counterfeit peptide 1,385 +1,385 ForgeryFinder (talk | contribs) start article on the testing subject
  7. (diff | hist) m 07:30 Aspiration risk under anaesthesia 2,915 +269 SurmountSurma (talk | contribs) ce per PP:MOS [rollback]
  8. (diff | hist) m 04:15 Missed dose 3,355 +215 FiveOhThreeB (talk | contribs) add the beyond-use interval with the storage condition it assumes [rollback]
  9. (diff | hist) 02:43 Underfilling 1,727 ±0 ReportReaderRilla (talk | contribs) add the note that self-submitted reports are a self-selected sample [rollback]

1 December 2024

  1. (diff | hist) 23:07 WuXi TIDES 7,447 +336 LotTraceLuka (talk | contribs) add the see-also to the certificate-of-analysis article [rollback]
  2. (diff | hist) m 22:28 Glucose-dependent insulinotropic polypeptide 5,577 +118 BacWaterBarnaby (talk | contribs) rm the sentence implying the hormone is a drug [rollback]
  3. (diff | hist) 19:47 Survodutide 2,514 ±0 IcodecIndra (talk | contribs) attribute the mechanism claim to the review rather than stating it flatly [rollback]
  4. (diff | hist) m 19:30 Good manufacturing practice 2,501 ±0 DrTitration (talk | contribs) attribute the compounding statement to the pharmacy board that issued it [rollback]
  5. (diff | hist) 18:37 Peptide supply chain 3,807 +268 LotTraceLuka (talk | contribs) rm the vendor-specific packaging detail; not general enough for the article [rollback]
  6. (diff | hist) m 14:15 ChinaPeptides 3,950 ±0 IcodecIndra (talk | contribs) add category for suppliers in China [rollback]
  7. (diff | hist) 12:22 Melanotan II 1,970 +793 ShortDescShai (talk | contribs) split the pharmacology section from the marketing history [rollback]
  8. (diff | hist) 10:39 Proglucagon 4,138 +673 COA_Colwyn (talk | contribs) add see also to the sister hormone [rollback]
  9. (diff | hist) 06:21 Liraglutide 3,273 ±0 MolarMassMaeve (talk | contribs) move the trade-name history out of the lead and into §Regulatory history [rollback]
  10. (diff | hist) m 04:05 Test report forgery 2,860 +541 LedgerLysander (talk | contribs) expand §Consequences for how documents are used [rollback]
  11. (diff | hist) 01:31 Body composition assessment 1,910 ±0 CoI_Corin (talk | contribs) expand §Lean mass loss during weight reduction [rollback]

30 November 2024

  1. (diff | hist) 21:15 Shanghai Sigma-Audley New Material Technology 2,703 ±0 ForgeryFinder (talk | contribs) clarify that a registered business scope is a licensing fact, not a quality assurance [rollback]
  2. (diff | hist) 20:18 Insulin syringe 3,647 +758 VerifyFirstVida (talk | contribs) state the syringe graduation the unit figure assumes [rollback]
  3. (diff | hist) 18:25 Certificate of analysis 5,485 ±0 PurityClaimPia (talk | contribs) add the point that reports reaching this wiki are not a sample of anything [rollback]
  4. (diff | hist) m b 15:17 Customs seizure 1,799 ±0 CategoryBot (talk | contribs) bot: expand DOI to full citation [rollback]
  5. (diff | hist) 07:03 Dual incretin agonist 4,447 +982 IncretinIvo (talk | contribs) add the molecular formula to the infobox [rollback]
  6. (diff | hist) 04:28 FLOW trial 2,601 ±0 HedgeHedda (talk | contribs) add the number randomised and the number completing [rollback]
  7. (diff | hist) 02:57 Residual solvent 2,880 ±0 TechnicianTeal (talk | contribs) add the cross-link to the compendial chapter [rollback]
  8. (diff | hist) 01:22 Crude peptide 2,632 ±0 FmocFrancis (talk | contribs) state the residual-moisture target with the method it is measured by [rollback]
  9. (diff | hist) N 01:09 Peptide harm reduction 1,258 +1,258 HarmReductionHen (talk | contribs) create article — access and cost stub

29 November 2024

  1. (diff | hist) 22:08 Nantong Guangyuan Chemical 6,614 +170 VerifyFirstVida (talk | contribs) add the research-use-only statement to the lead rather than only the footer [rollback]
  2. (diff | hist) m b 21:29 Retention time 2,901 ±0 StubSorterBot (talk | contribs) bot: flag bare reference [rollback]
  3. (diff | hist) m b 21:13 Glucagon-like peptide-1 8,227 ±0 StubSorterBot (talk | contribs) bot: sort category members [rollback]
  4. (diff | hist) 14:42 Incretin effect 4,982 ±0 TesamorelinTeg (talk | contribs) add the postprandial time course with its units [rollback]
  5. (diff | hist) 14:27 Analytical method validation 3,011 +32 FootnoteFyfe (talk | contribs) give the limit of quantitation with the signal-to-noise ratio it assumes [rollback]
  6. (diff | hist) 14:14 List of GLP-1 receptor agonists 2,606 ±0 RedirectRini (talk | contribs) reconcile the list against the category; two articles were missing [rollback]
  7. (diff | hist) 13:05 Peptide stability table 1,273 ±0 Chromatokid (talk | contribs) add the note that vial overfill is not assumed [rollback]
  8. (diff | hist) 11:18 Area percent purity 3,599 ±0 UnitsUrsula (talk | contribs) add the cross-link to the compendial chapter [rollback]
  9. (diff | hist) 09:52 International nonproprietary name 2,241 +178 CagriCass (talk | contribs) space between number and unit per PP:MOS [rollback]
  10. (diff | hist) m b 09:16 Oral semaglutide 3,213 +676 CategoryBot (talk | contribs) bot: normalise citation format [rollback]
  11. (diff | hist) 08:27 Bacteriostatic water 3,438 +607 TitrationTheo (talk | contribs) move a stray full stop inside the reference [rollback]
  12. (diff | hist) 08:19 Amino acid analysis 2,367 +324 TirzTaxonomist (talk | contribs) split §Principle from §Practical limitations [rollback]
  13. (diff | hist) 07:08 Tianjin Finder Chemical 3,766 +696 TallySheetTad (talk | contribs) add category for suppliers in China [rollback]
  14. (diff | hist) N 05:50 Peptide stability table 1,273 +1,273 BalanceBirdie (talk | contribs) new article: reference tool, expansion welcome
  15. (diff | hist) 02:17 Active pharmaceutical ingredient 1,752 +609 LabelLibby (talk | contribs) add the customs-detention point with its source [rollback]

28 November 2024

  1. (diff | hist) m 23:39 Contract development and manufacturing organisation 2,252 ±0 CouplingCillian (talk | contribs) expand §Consequences for reading documentation [rollback]
  2. (diff | hist) m 21:23 Number needed to treat 2,730 +450 TelehealthTruus (talk | contribs) expand §Calculation [rollback]
  3. (diff | hist) 18:40 Amylin 3,238 ±0 DiffWatchDov (talk | contribs) close an unbalanced quotation mark [rollback]
  4. (diff | hist) 14:58 Reconstitution of lyophilised peptides 3,676 +558 LeanMassLars (talk | contribs) sentence case in headings per PP:MOS [rollback]
  5. (diff | hist) 13:38 Prescribing information 2,473 ±0 GlossaryGleb (talk | contribs) alphabetise the see-also list [rollback]
  6. (diff | hist) 09:25 Purity claim inflation 2,887 +217 BlindSampleBrid (talk | contribs) correct the description of the sampling procedure [rollback]
  7. (diff | hist) m 07:34 Chain of custody 2,966 ±0 GHK_Gwendolen (talk | contribs) convert the service comparison to a table [rollback]
  8. (diff | hist) m 07:33 Hypoglycaemia 3,334 +844 ChainCustodyChad (talk | contribs) add the contraindication with its rationale [rollback]
  9. (diff | hist) 06:16 Custom peptide synthesis 2,690 ±0 ResinRhoswen (talk | contribs) expand §Documentation for custom work [rollback]
  10. (diff | hist) m 05:08 High-performance liquid chromatography 4,315 +112 KarlFischerKit (talk | contribs) convert a hard-coded date to the house format [rollback]
  11. (diff | hist) 03:15 Janoshik Analytical 3,638 ±0 RedirectRini (talk | contribs) British spelling per PP:MOS [rollback]

27 November 2024

  1. (diff | hist) 21:24 Batch number 3,013 +31 COA_Colwyn (talk | contribs) state the date range the submitted set covers [rollback]
  2. (diff | hist) 18:31 Hunan Aslsen Technology 5,407 +501 FootnoteFyfe (talk | contribs) expand §Ordering and availability [rollback]
  3. (diff | hist) N 09:00 Personal importation policy 1,572 +1,572 StabilityStig (talk | contribs) create article — regulatory stub
  4. (diff | hist) 08:35 Lyophilisation 10,767 +508 CrossRefCleve (talk | contribs) state that overlay gas is used and name it [rollback]
  5. (diff | hist) m 08:07 Peptide aggregation 3,081 +38 LOD_Lorcan (talk | contribs) fix a broken wikilink [rollback]
  6. (diff | hist) m b 06:09 Solid-phase peptide synthesis 3,963 +102 ArchiveBot (talk | contribs) bot: normalise temperature formatting [rollback]
  7. (diff | hist) 03:38 Semaglutide 6,658 ±0 Chromatokid (talk | contribs) add a hatnote pointing at the analogue with the similar name [rollback]
  8. (diff | hist) m 03:31 VendorInvestigate 2,881 +31 PurityClaimPia (talk | contribs) alphabetise the see-also list [rollback]
  9. (diff | hist) 03:23 Dose escalation schedule 2,748 +29 SyringeSybille (talk | contribs) add the disclaimer that this is not administration guidance [rollback]
  10. (diff | hist) m b 01:02 Adverse effects of GLP-1 receptor agonists 4,129 +958 CategoryBot (talk | contribs) bot: normalise citation format [rollback]
  11. (diff | hist) 00:38 USP General Chapter 71 1,714 ±0 GlossaryGaspar (talk | contribs) state the titration endpoint and the reagent factor [rollback]

26 November 2024

  1. (diff | hist) 21:17 Sarcopenia 1,173 ±0 Peptide_Pete (talk | contribs) add the body-composition measurement method to the comparison [rollback]
  2. (diff | hist) 18:06 SURMOUNT trial programme 2,702 +34 PatientPanelPru (talk | contribs) give the absolute risk difference alongside the relative one [rollback]
  3. (diff | hist) 14:22 Shanghai Sigma-Audley New Material Technology 2,703 ±0 SurrogateSunday (talk | contribs) space between number and unit per PP:MOS [rollback]
  4. (diff | hist) m 10:47 Bachem Holding (Suzhou) 4,853 +222 DiagramDelphine (talk | contribs) add the note that self-published material is usable only for what it states about itself [rollback]
  5. (diff | hist) 03:39 Reconstitution calculator 3,369 ±0 SourceHunterSile (talk | contribs) copyedit [rollback]
  6. (diff | hist) 00:17 SURPASS trial programme 3,661 +34 GastroparesisGwen (talk | contribs) cite the trial publication rather than the sponsor press release [rollback]

25 November 2024

  1. (diff | hist) m 20:54 Gastric emptying 3,836 +44 Ref_Desk_Ron (talk | contribs) convert the receptor-distribution list to a table [rollback]
  2. (diff | hist) 18:37 Sterile water for injection 3,062 +643 OralSemaOswin (talk | contribs) add the diluent volume the example assumes [rollback]
  3. (diff | hist) 14:12 Contraindications of incretin therapy 2,065 ±0 SiteReactionSuz (talk | contribs) rm a duplicated category [rollback]
  4. (diff | hist) 13:35 Body composition assessment 1,910 ±0 BlankVialBo (talk | contribs) expand §Methods and their precision [rollback]
  5. (diff | hist) 10:53 Fasting insulin 2,254 ±0 ApoB_Aurelio (talk | contribs) expand §Why it needs glucose alongside it [rollback]
  6. (diff | hist) 09:03 Beyond-use date 6,130 +1,252 EndotoxinEd (talk | contribs) consistent en dashes in ranges [rollback]
  7. (diff | hist) N 09:00 Active pharmaceutical ingredient 1,143 +1,143 SyringeSybille (talk | contribs) start article on the regulatory position
  8. (diff | hist) m 04:18 CagriSema 2,861 +600 LabRangeLindy (talk | contribs) add the structural figure and caption it properly [rollback]
  9. (diff | hist) m b 04:02 PeptideMeter 2,876 ±0 CiteBot (talk | contribs) bot: flag bare reference [rollback]
  10. (diff | hist) m 03:34 Amino acid analysis 2,043 ±0 COA_Colwyn (talk | contribs) correct the integration description — valley-to-valley, not drop-line [rollback]

24 November 2024

  1. (diff | hist) 16:52 Growth hormone secretagogue 2,667 +825 MOTSc_Mira (talk | contribs) the solubility figure needs its solvent stated [rollback]
  2. (diff | hist) m b 15:26 Satiety signalling 3,938 +704 CiteBot (talk | contribs) bot: sort category members [rollback]
  3. (diff | hist) 15:02 Research use only 4,722 +996 SelectTrialSam (talk | contribs) add the jurisdiction to the legal statement [rollback]
  4. (diff | hist) m 14:43 Glucagon 4,787 +590 DulaglutideDug (talk | contribs) space between number and unit per PP:MOS [rollback]
  5. (diff | hist) m b 14:37 Exenatide 2,935 ±0 ArchiveBot (talk | contribs) bot: add drug-class category [rollback]
  6. (diff | hist) 14:11 SELECT trial 3,502 ±0 BlindSampleBrid (talk | contribs) attribute the subgroup finding as exploratory [rollback]
  7. (diff | hist) 09:23 Chinese Peptide Company 6,673 +782 PeakShapePol (talk | contribs) add the note that self-published material is usable only for what it states about itself [rollback]
  8. (diff | hist) 08:37 Talk:Shanghai Sigma-Audley New Material Technology 1,033 +60 NotabilityNoa (talk | contribs) /* Notability and the registered business scope */ reply
  9. (diff | hist) m b 06:45 Arcuate nucleus 3,033 ±0 ArchiveBot (talk | contribs) bot: normalise citation format [rollback]